Global Animal Antibiotic and Antimicrobial Market 2026 by Company, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Animal Antibiotic and Antimicrobial by Type
- 1.3.1 Overview: Global Animal Antibiotic and Antimicrobial Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Animal Antibiotic and Antimicrobial Consumption Value Market Share by Type in 2025
- 1.3.3 Tetracyclines
- 1.3.4 Macrolides
- 1.3.5 Beta-Lactams
- 1.3.6 Aminoglycosides
- 1.3.7 Others
- 1.4 Classification of Animal Antibiotic and Antimicrobial by Mode Of Action Type
- 1.4.1 Overview: Global Animal Antibiotic and Antimicrobial Market Size by Mode Of Action Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Animal Antibiotic and Antimicrobial Consumption Value Market Share by Mode Of Action Type in 2025
- 1.4.3 Bacteriostatic
- 1.4.4 Bactericidal
- 1.4.5 Others
- 1.5 Classification of Animal Antibiotic and Antimicrobial by Formulation Type
- 1.5.1 Overview: Global Animal Antibiotic and Antimicrobial Market Size by Formulation Type: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Animal Antibiotic and Antimicrobial Consumption Value Market Share by Formulation Type in 2025
- 1.5.3 Feed Additive
- 1.5.4 Oral Solution
- 1.5.5 Injectable
- 1.5.6 Topical
- 1.6 Global Animal Antibiotic and Antimicrobial Market by Application
- 1.6.1 Overview: Global Animal Antibiotic and Antimicrobial Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Poultry
- 1.6.3 Swine
- 1.6.4 Cattle
- 1.6.5 Aquaculture
- 1.6.6 Others
- 1.7 Global Animal Antibiotic and Antimicrobial Market Size & Forecast
- 1.8 Global Animal Antibiotic and Antimicrobial Market Size and Forecast by Region
- 1.8.1 Global Animal Antibiotic and Antimicrobial Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Animal Antibiotic and Antimicrobial Market Size by Region, (2021-2032)
- 1.8.3 North America Animal Antibiotic and Antimicrobial Market Size and Prospect (2021-2032)
- 1.8.4 Europe Animal Antibiotic and Antimicrobial Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Animal Antibiotic and Antimicrobial Market Size and Prospect (2021-2032)
- 1.8.6 South America Animal Antibiotic and Antimicrobial Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Animal Antibiotic and Antimicrobial Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Zoetis Inc.
- 2.1.1 Zoetis Inc. Details
- 2.1.2 Zoetis Inc. Major Business
- 2.1.3 Zoetis Inc. Animal Antibiotic and Antimicrobial Product and Solutions
- 2.1.4 Zoetis Inc. Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Zoetis Inc. Recent Developments and Future Plans
- 2.2 Elanco Animal Health
- 2.2.1 Elanco Animal Health Details
- 2.2.2 Elanco Animal Health Major Business
- 2.2.3 Elanco Animal Health Animal Antibiotic and Antimicrobial Product and Solutions
- 2.2.4 Elanco Animal Health Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Elanco Animal Health Recent Developments and Future Plans
- 2.3 Boehringer Ingelheim Animal Health
- 2.3.1 Boehringer Ingelheim Animal Health Details
- 2.3.2 Boehringer Ingelheim Animal Health Major Business
- 2.3.3 Boehringer Ingelheim Animal Health Animal Antibiotic and Antimicrobial Product and Solutions
- 2.3.4 Boehringer Ingelheim Animal Health Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Boehringer Ingelheim Animal Health Recent Developments and Future Plans
- 2.4 Merck Animal Health
- 2.4.1 Merck Animal Health Details
- 2.4.2 Merck Animal Health Major Business
- 2.4.3 Merck Animal Health Animal Antibiotic and Antimicrobial Product and Solutions
- 2.4.4 Merck Animal Health Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Merck Animal Health Recent Developments and Future Plans
- 2.5 Ceva Santé Animale
- 2.5.1 Ceva Santé Animale Details
- 2.5.2 Ceva Santé Animale Major Business
- 2.5.3 Ceva Santé Animale Animal Antibiotic and Antimicrobial Product and Solutions
- 2.5.4 Ceva Santé Animale Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ceva Santé Animale Recent Developments and Future Plans
- 2.6 Phibro Animal Health Corporation
- 2.6.1 Phibro Animal Health Corporation Details
- 2.6.2 Phibro Animal Health Corporation Major Business
- 2.6.3 Phibro Animal Health Corporation Animal Antibiotic and Antimicrobial Product and Solutions
- 2.6.4 Phibro Animal Health Corporation Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Phibro Animal Health Corporation Recent Developments and Future Plans
- 2.7 Huvepharma
- 2.7.1 Huvepharma Details
- 2.7.2 Huvepharma Major Business
- 2.7.3 Huvepharma Animal Antibiotic and Antimicrobial Product and Solutions
- 2.7.4 Huvepharma Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Huvepharma Recent Developments and Future Plans
- 2.8 Virbac
- 2.8.1 Virbac Details
- 2.8.2 Virbac Major Business
- 2.8.3 Virbac Animal Antibiotic and Antimicrobial Product and Solutions
- 2.8.4 Virbac Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Virbac Recent Developments and Future Plans
- 2.9 Vetoquinol
- 2.9.1 Vetoquinol Details
- 2.9.2 Vetoquinol Major Business
- 2.9.3 Vetoquinol Animal Antibiotic and Antimicrobial Product and Solutions
- 2.9.4 Vetoquinol Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Vetoquinol Recent Developments and Future Plans
- 2.10 Pharmgate Animal Health
- 2.10.1 Pharmgate Animal Health Details
- 2.10.2 Pharmgate Animal Health Major Business
- 2.10.3 Pharmgate Animal Health Animal Antibiotic and Antimicrobial Product and Solutions
- 2.10.4 Pharmgate Animal Health Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Pharmgate Animal Health Recent Developments and Future Plans
- 2.11 Norbrook Laboratories
- 2.11.1 Norbrook Laboratories Details
- 2.11.2 Norbrook Laboratories Major Business
- 2.11.3 Norbrook Laboratories Animal Antibiotic and Antimicrobial Product and Solutions
- 2.11.4 Norbrook Laboratories Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Norbrook Laboratories Recent Developments and Future Plans
- 2.12 Dechra Pharmaceuticals
- 2.12.1 Dechra Pharmaceuticals Details
- 2.12.2 Dechra Pharmaceuticals Major Business
- 2.12.3 Dechra Pharmaceuticals Animal Antibiotic and Antimicrobial Product and Solutions
- 2.12.4 Dechra Pharmaceuticals Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Dechra Pharmaceuticals Recent Developments and Future Plans
- 2.13 Zydus Animal Health
- 2.13.1 Zydus Animal Health Details
- 2.13.2 Zydus Animal Health Major Business
- 2.13.3 Zydus Animal Health Animal Antibiotic and Antimicrobial Product and Solutions
- 2.13.4 Zydus Animal Health Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Zydus Animal Health Recent Developments and Future Plans
- 2.14 Zhejiang Hisun Pharmaceutical Co
- 2.14.1 Zhejiang Hisun Pharmaceutical Co Details
- 2.14.2 Zhejiang Hisun Pharmaceutical Co Major Business
- 2.14.3 Zhejiang Hisun Pharmaceutical Co Animal Antibiotic and Antimicrobial Product and Solutions
- 2.14.4 Zhejiang Hisun Pharmaceutical Co Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Zhejiang Hisun Pharmaceutical Co Recent Developments and Future Plans
- 2.15 Hunan Weida Technology Co
- 2.15.1 Hunan Weida Technology Co Details
- 2.15.2 Hunan Weida Technology Co Major Business
- 2.15.3 Hunan Weida Technology Co Animal Antibiotic and Antimicrobial Product and Solutions
- 2.15.4 Hunan Weida Technology Co Animal Antibiotic and Antimicrobial Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Hunan Weida Technology Co Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Animal Antibiotic and Antimicrobial Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Animal Antibiotic and Antimicrobial by Company Revenue
- 3.2.2 Top 3 Animal Antibiotic and Antimicrobial Players Market Share in 2025
- 3.2.3 Top 6 Animal Antibiotic and Antimicrobial Players Market Share in 2025
- 3.3 Animal Antibiotic and Antimicrobial Market: Overall Company Footprint Analysis
- 3.3.1 Animal Antibiotic and Antimicrobial Market: Region Footprint
- 3.3.2 Animal Antibiotic and Antimicrobial Market: Company Product Type Footprint
- 3.3.3 Animal Antibiotic and Antimicrobial Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Animal Antibiotic and Antimicrobial Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Animal Antibiotic and Antimicrobial Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Animal Antibiotic and Antimicrobial Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Animal Antibiotic and Antimicrobial Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Animal Antibiotic and Antimicrobial Consumption Value by Type (2021-2032)
- 6.2 North America Animal Antibiotic and Antimicrobial Market Size by Application (2021-2032)
- 6.3 North America Animal Antibiotic and Antimicrobial Market Size by Country
- 6.3.1 North America Animal Antibiotic and Antimicrobial Consumption Value by Country (2021-2032)
- 6.3.2 United States Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 6.3.3 Canada Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Animal Antibiotic and Antimicrobial Consumption Value by Type (2021-2032)
- 7.2 Europe Animal Antibiotic and Antimicrobial Consumption Value by Application (2021-2032)
- 7.3 Europe Animal Antibiotic and Antimicrobial Market Size by Country
- 7.3.1 Europe Animal Antibiotic and Antimicrobial Consumption Value by Country (2021-2032)
- 7.3.2 Germany Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 7.3.3 France Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 7.3.5 Russia Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 7.3.6 Italy Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Animal Antibiotic and Antimicrobial Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Animal Antibiotic and Antimicrobial Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Animal Antibiotic and Antimicrobial Market Size by Region
- 8.3.1 Asia-Pacific Animal Antibiotic and Antimicrobial Consumption Value by Region (2021-2032)
- 8.3.2 China Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 8.3.3 Japan Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 8.3.5 India Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 8.3.7 Australia Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Animal Antibiotic and Antimicrobial Consumption Value by Type (2021-2032)
- 9.2 South America Animal Antibiotic and Antimicrobial Consumption Value by Application (2021-2032)
- 9.3 South America Animal Antibiotic and Antimicrobial Market Size by Country
- 9.3.1 South America Animal Antibiotic and Antimicrobial Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Animal Antibiotic and Antimicrobial Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Animal Antibiotic and Antimicrobial Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Animal Antibiotic and Antimicrobial Market Size by Country
- 10.3.1 Middle East & Africa Animal Antibiotic and Antimicrobial Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
- 10.3.4 UAE Animal Antibiotic and Antimicrobial Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Animal Antibiotic and Antimicrobial Market Drivers
- 11.2 Animal Antibiotic and Antimicrobial Market Restraints
- 11.3 Animal Antibiotic and Antimicrobial Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Animal Antibiotic and Antimicrobial Industry Chain
- 12.2 Animal Antibiotic and Antimicrobial Upstream Analysis
- 12.3 Animal Antibiotic and Antimicrobial Midstream Analysis
- 12.4 Animal Antibiotic and Antimicrobial Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Animal Antibiotic and Antimicrobial market size was valued at US$ 2084 million in 2025 and is forecast to a readjusted size of US$ 3188 million by 2032 with a CAGR of 6.5% during review period.
Animal Antibiotic and Antimicrobials are pharmaceutical compounds used in veterinary medicine and livestock production to prevent, control, and treat bacterial and microbial infections in animals, including livestock, poultry, aquaculture species, and companion animals, while also supporting herd health, reducing mortality, and improving productivity under regulated usage conditions to mitigate antimicrobial resistance risks.
The Animal Antibiotic and Antimicrobial industry chain consists of upstream suppliers producing active pharmaceutical ingredients such as tetracyclines, macrolides, beta lactams, fluoroquinolones, and sulfonamides through fermentation or chemical synthesis along with excipients, stabilizers, and formulation carriers, while midstream manufacturers formulate and process these compounds into feed additives, premixes, powders, liquids, and injectable veterinary medicines under strict GMP and regulatory compliance systems, and downstream end users including livestock farms, poultry producers, swine and ruminant operations, aquaculture farms, veterinary hospitals, and animal feed manufacturers apply these products for disease prevention, treatment, productivity improvement, and herd health management across global animal production systems.
Animal Antibiotic and Antimicrobial projects under construction and planned are driven by expanding global livestock production, rising demand for animal protein, and modernization of veterinary pharmaceutical manufacturing capacity in Asia-Pacific, Latin America, and Africa, with investments focusing on upgrading fermentation-based API facilities, expanding premix and injectable production lines, and developing compliance-driven manufacturing systems aligned with antimicrobial resistance regulations, while developed markets emphasize restructuring production toward high-value therapeutic antibiotics and precision veterinary formulations, supported by integration of animal health platforms, expansion of veterinary distribution networks, and adoption of alternative antimicrobial strategies in large-scale industrial farming systems worldwide.
2025 Global Market Average Gross Profit Margin: 30%.
The animal antibiotic and antimicrobial market is a foundational segment of global animal health and livestock production systems. Demand is driven by large-scale meat, dairy, and aquaculture production where disease control and productivity optimization are critical. Poultry and swine sectors represent the largest consumption segments due to intensive farming practices. Asia-Pacific dominates global demand because of its large livestock population and rapid protein consumption growth. North America and Europe show slower growth due to strict antimicrobial resistance regulations and reduced non-therapeutic usage. The market is shifting from growth promotion applications toward therapeutic and preventive veterinary uses. Regulatory frameworks are becoming increasingly stringent worldwide, limiting indiscriminate antibiotic use. This has accelerated adoption of antimicrobial stewardship programs across animal production systems. Technological innovation is focused on targeted delivery systems, controlled-release formulations, and improved bioavailability. Integration of antibiotics with vaccines, probiotics, and biosecurity systems is becoming more common. Competitive dynamics are highly consolidated, dominated by global animal health pharmaceutical companies. Supply chain integration between feed manufacturers, pharmaceutical producers, and livestock integrators is strengthening operational efficiency. Emerging markets continue to rely heavily on antibiotics due to cost-effectiveness and production intensity. However, alternative solutions such as probiotics and natural antimicrobials are gradually gaining share. Overall, the market is transitioning toward regulated, precision-based, and sustainability-oriented animal health management systems.
This report is a detailed and comprehensive analysis for global Animal Antibiotic and Antimicrobial market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Animal Antibiotic and Antimicrobial market size and forecasts, in consumption value ($ Million), 2021-2032
Global Animal Antibiotic and Antimicrobial market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Animal Antibiotic and Antimicrobial market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Animal Antibiotic and Antimicrobial market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Animal Antibiotic and Antimicrobial
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Animal Antibiotic and Antimicrobial market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, Huvepharma, Virbac, Vetoquinol, Pharmgate Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Animal Antibiotic and Antimicrobial market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tetracyclines
Macrolides
Beta-Lactams
Aminoglycosides
Others
Market segment by Mode Of Action Type
Bacteriostatic
Bactericidal
Others
Market segment by Formulation Type
Feed Additive
Oral Solution
Injectable
Topical
Market segment by Application
Poultry
Swine
Cattle
Aquaculture
Others
Market segment by players, this report covers
Zoetis Inc.
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
Ceva Santé Animale
Phibro Animal Health Corporation
Huvepharma
Virbac
Vetoquinol
Pharmgate Animal Health
Norbrook Laboratories
Dechra Pharmaceuticals
Zydus Animal Health
Zhejiang Hisun Pharmaceutical Co
Hunan Weida Technology Co
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Animal Antibiotic and Antimicrobial product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Animal Antibiotic and Antimicrobial, with revenue, gross margin, and global market share of Animal Antibiotic and Antimicrobial from 2021 to 2026.
Chapter 3, the Animal Antibiotic and Antimicrobial competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Animal Antibiotic and Antimicrobial market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal Antibiotic and Antimicrobial.
Chapter 13, to describe Animal Antibiotic and Antimicrobial research findings and conclusion.